Literature DB >> 25977230

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.

Robert R Jenq1, Ying Taur2, Sean M Devlin3, Doris M Ponce4, Jenna D Goldberg4, Katya F Ahr5, Eric R Littmann6, Lilan Ling5, Asia C Gobourne5, Liza C Miller5, Melissa D Docampo5, Jonathan U Peled4, Nicholas Arpaia5, Justin R Cross7, Tatanisha K Peets8, Melissa A Lumish5, Yusuke Shono5, Jarrod A Dudakov5, Hendrik Poeck5, Alan M Hanash4, Juliet N Barker4, Miguel-Angel Perales4, Sergio A Giralt4, Eric G Pamer2, Marcel R M van den Brink4.   

Abstract

The relationship between intestinal microbiota composition and acute graft-versus-host disease (GVHD) after allogeneic blood/marrow transplantation (allo-BMT) is not well understood. Intestinal bacteria have long been thought to contribute to GVHD pathophysiology, but recent animal studies in nontransplant settings have found that anti-inflammatory effects are mediated by certain subpopulations of intestinal commensals. Hypothesizing that a more nuanced relationship may exist between the intestinal bacteria and GVHD, we evaluated the fecal bacterial composition of 64 patients 12 days after BMT. We found that increased bacterial diversity was associated with reduced GVHD-related mortality. Furthermore, harboring increased amounts of bacteria belonging to the genus Blautia was associated with reduced GVHD lethality in this cohort and was confirmed in another independent cohort of 51 patients from the same institution. Blautia abundance was also associated with improved overall survival. We evaluated the abundance of Blautia with respect to clinical factors and found that loss of Blautia was associated with treatment with antibiotics that inhibit anaerobic bacteria and receiving total parenteral nutrition for longer durations. We conclude that increased abundance of commensal bacteria belonging to the Blautia genus is associated with reduced lethal GVHD and improved overall survival.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Graft-versus-host disease; Intestinal bacteria

Mesh:

Year:  2015        PMID: 25977230      PMCID: PMC4516127          DOI: 10.1016/j.bbmt.2015.04.016

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  53 in total

Review 1.  Epithelial antimicrobial defence of the skin and intestine.

Authors:  Richard L Gallo; Lora V Hooper
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

2.  Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

Authors:  Jasmohan S Bajaj; Phillip B Hylemon; Jason M Ridlon; Douglas M Heuman; Kalyani Daita; Melanie B White; Pamela Monteith; Nicole A Noble; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-19       Impact factor: 4.052

Review 3.  Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.

Authors:  Sebastian Theurich; Hans Fischmann; Alexander Shimabukuro-Vornhagen; Jens M Chemnitz; Udo Holtick; Christof Scheid; Nicole Skoetz; Michael von Bergwelt-Baildon
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

4.  Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  Ying Taur; Joao B Xavier; Lauren Lipuma; Carles Ubeda; Jenna Goldberg; Asia Gobourne; Yeon Joo Lee; Krista A Dubin; Nicholas D Socci; Agnes Viale; Miguel-Angel Perales; Robert R Jenq; Marcel R M van den Brink; Eric G Pamer
Journal:  Clin Infect Dis       Date:  2012-06-20       Impact factor: 9.079

5.  High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health.

Authors:  Wendy R Russell; Silvia W Gratz; Sylvia H Duncan; Grietje Holtrop; Jennifer Ince; Lorraine Scobbie; Garry Duncan; Alexandra M Johnstone; Gerald E Lobley; R John Wallace; Garry G Duthie; Harry J Flint
Journal:  Am J Clin Nutr       Date:  2011-03-09       Impact factor: 7.045

6.  What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score.

Authors:  Margaret L MacMillan; Todd E DeFor; Daniel J Weisdorf
Journal:  Br J Haematol       Date:  2012-04-06       Impact factor: 6.998

7.  Reduced-intensity conditioning allogeneic stem cell transplantation in pediatric patients and subsequent supportive care.

Authors:  Catherine Barrell; Danielle Dietzen; Zhezhen Jin; Sharon Pinchefsky; Kristen Petrillo; Prakash Satwani
Journal:  Oncol Nurs Forum       Date:  2012-11       Impact factor: 2.172

8.  Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.

Authors:  R Storb; R L Prentice; C D Buckner; R A Clift; F Appelbaum; J Deeg; K Doney; J A Hansen; M Mason; J E Sanders; J Singer; K M Sullivan; R P Witherspoon; E D Thomas
Journal:  N Engl J Med       Date:  1983-02-10       Impact factor: 91.245

9.  Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation.

Authors:  Robert R Jenq; Carles Ubeda; Ying Taur; Clarissa C Menezes; Raya Khanin; Jarrod A Dudakov; Chen Liu; Mallory L West; Natalie V Singer; Michele J Equinda; Asia Gobourne; Lauren Lipuma; Lauren F Young; Odette M Smith; Arnab Ghosh; Alan M Hanash; Jenna D Goldberg; Kazutoshi Aoyama; Bruce R Blazar; Eric G Pamer; Marcel R M van den Brink
Journal:  J Exp Med       Date:  2012-04-30       Impact factor: 14.307

10.  Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer.

Authors:  Weiguang Chen; Fanlong Liu; Zongxin Ling; Xiaojuan Tong; Charlie Xiang
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

View more
  252 in total

Review 1.  Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Authors:  Tessa M Andermann; Andrew Rezvani; Ami S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

2.  Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Bianca Harris; Sejal M Morjaria; Eric R Littmann; Alexander I Geyer; Diane E Stover; Juliet N Barker; Sergio A Giralt; Ying Taur; Eric G Pamer
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

Review 3.  Microbiome-intestine cross talk during acute graft-versus-host disease.

Authors:  Hind Rafei; Robert R Jenq
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

4.  Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity.

Authors:  Mathilde Payen; Ioannis Nicolis; Marie Robin; David Michonneau; Johanne Delannoye; Camille Mayeur; Nathalie Kapel; Béatrice Berçot; Marie-José Butel; Jérôme Le Goff; Gérard Socié; Clotilde Rousseau
Journal:  Blood Adv       Date:  2020-05-12

Review 5.  New and emerging therapies for acute and chronic graft versus host disease.

Authors:  LaQuisa Hill; Amin Alousi; Partow Kebriaei; Rohtesh Mehta; Katayoun Rezvani; Elizabeth Shpall
Journal:  Ther Adv Hematol       Date:  2017-11-28

Review 6.  Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients.

Authors:  Andrew Y Koh
Journal:  Clin Chem       Date:  2017-07-18       Impact factor: 8.327

Review 7.  Gut Microbiome Modulates Response to Cancer Immunotherapy.

Authors:  Md Abdul Wadud Khan; Gabriel Ologun; Reetakshi Arora; Jennifer L McQuade; Jennifer A Wargo
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

8.  Role of gut flora after bone marrow transplantation.

Authors:  Jonathan U Peled; Robert R Jenq; Ernst Holler; Marcel R M van den Brink
Journal:  Nat Microbiol       Date:  2016-03-29       Impact factor: 17.745

Review 9.  Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation.

Authors:  J Whangbo; J Ritz; A Bhatt
Journal:  Bone Marrow Transplant       Date:  2016-08-15       Impact factor: 5.483

10.  Specific gut microbiome signature predicts the early-stage lung cancer.

Authors:  Yajuan Zheng; Zhaoyuan Fang; Yun Xue; Jian Zhang; Junjie Zhu; Renyuan Gao; Shun Yao; Yi Ye; Shihui Wang; Changdong Lin; Shiyang Chen; Hsinyi Huang; Liang Hu; Ge-Ning Jiang; Huanlong Qin; Peng Zhang; Jianfeng Chen; Hongbin Ji
Journal:  Gut Microbes       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.